Allurion Technologies Inc. is cleared by regulators in France to resume sales of its swallowable gastric balloon to treat ...

Allurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Outset Medical (OM – Research Report) and ...

Allurion Technologies today announced the relaunch of its Allurion Balloon in France following regulatory clearance to resume ...

The data for Allurion Technologies Inc. (NASDAQ: ALUR) herein utilizes proprietary algorithms produced by Stock Traders Daily and refined since the turn of the century.

Allurion Technologies (ALUR) announced that it is relaunching the Allurion Balloon in France after ANSM, the French regulatory authority, ...

Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced that it is relaunching the Allurion Balloon in France after ANSM, the ...

The mean of analysts' price targets for Allurion Technologies, Inc. (ALUR) points to a 374.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...

The Allurion swallowable intragastric balloon offers a safe, effective and minimally invasive method of losing weight.

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

Technically, Allurion Technologies Inc. (NASDAQ: ALUR) provides opportunities for traders who are watching the price of the stock oscillate over time. This is a static report, the data below was valid ...